Post-marketing Registry Study of Infliximab for Injection in Chinese Pediatric Crohn's Disease Patients
Clinical trial NCT05906576 · RECRUITING
Trial details
- NCT number
- NCT05906576
- Sponsor
- Taizhou Mabtech Pharmaceutical Co.,Ltd
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-21
- Primary completion
- 2026-11-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.